$80K - $100K(Ladders Estimates)
The Johns Hopkins Hospital
The Clinical Pharmacy Specialist will work collaboratively with members of the healthcare team, including physicians, nurses, social workers, dietitians, and other pharmacists. They will provide drug information and education to patients, students, residents, pharmacists, and other healthcare practitioners. They will serve as a preceptor for pharmacy residents of ASHP accredited PGY-1 pharmacy practice and PGY-2 specialty practice programs. Additionally, the successful candidate will support drug research conducted by the institution and seek to assume a leadership role in the profession of pharmacy.
The Clinical Pharmacy Specialist will be responsible for the provision and oversight of pharmacotherapy for patients on the medical oncology service in the acute care setting. The specialist will work with the incumbent medical oncology clinical pharmacy specialist to develop a plan for cross coverage and shared service responsibilities. Additionally, the specialist will work with the incumbent medical oncology specialist to evaluate further growth and development of the gynecologic oncology clinical services.
The medical oncology service has two teams, with an average census of 10 to 15 patients per team. The Clinical Pharmacy Specialist will be responsible for attending multidisciplinary rounds for one of these teams. Additionally, they will work closely with the pharmacy generalist covering the inpatient gynecologic oncology service, which is managed by surgeons, gynecologic oncology fellows, and advanced practitioners. Responsibilities for both services will include assisting with pharmacy–related questions and clinical issues, providing patient education with a focus on chemotherapy and discharge medications, collaborating with clinical dietitians to order and monitor parenteral nutrition, and participating in antimicrobial stewardship activities.
Additionally, the Clinical Pharmacy Specialist will work with the incumbent to assess and evaluate opportunities for continued expansion of inpatient and ambulatory pharmacy services for the gynecologic malignancies patient population.
Valid Through: 2019-10-21